While the investment in ULIPs is getting more criticism than other investment options by market regulator SEBI, but it has been noted then the money invested in the ULIPs may offer much more than the investor could have desired for.

In fact, according to the past records, high mortality benefits that can be as high as 50 times the annual premium or may even jump higher as per the examples set in the industry.

Moreover, companies like HDFC Standard Life offer up to 40 times the life cover on all its products under the Ulips category. Even Aegon Religare Life's Protect Gain and ICICI Prudential's LifeTime Maxima for that matter offer up to 50 times mortality cover to the investor.

MetLife Insurance's Met Smart Life offers life cover up to 100 times the annual premium making ULIPs a very lucrative option to stay invested in. It is a typical scenario of the higher risk cover, the higher mortality charges and hence less money is invested in the equity market.

However, some experts advice that ULIPs are not a safe option in case of higher life cover up to multiples of 50-60 times.